Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers
| Autor: | Allan Ben Smith, Melissa Grand, Pinky Patel, Jennifer Aung, Geoff P. Delaney, Kelsey Dobell-Brown, Afaf Girgis, Joseph Descallar, Meera Agar, Nasreen Kaadan |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Language barrier Logistic regression 03 medical and health sciences 0302 clinical medicine Neoplasms medicine Humans 030212 general & internal medicine Patient participation Aged Neoplasm Staging Retrospective Studies Clinical Trials as Topic business.industry Communication Barriers Retrospective cohort study Cultural Diversity General Medicine Odds ratio Middle Aged Health equity Clinical trial Oncology 030220 oncology & carcinogenesis Family medicine Limited English proficiency Physical therapy Female New South Wales Patient Participation business |
| Zdroj: | Asia-Pacific Journal of Clinical Oncology. 14:52-60 |
| ISSN: | 1743-7555 |
| Popis: | Aim Clinical trials play a critical role in advancing cancer care, but international research shows that few cancer patients, particularly culturally and linguistically diverse (CALD) patients, participate in trials. This limits generalizability of trial results and increases health disparities. This study aimed to establish rates and correlates of trial participation among CALD patients in South Western Sydney Local Health District (SWSLHD), a highly culturally diverse area. Methods Data from all cancer patients diagnosed and/or treated in SWSLHD from January 2006 to July 2016 were analyzed retrospectively. The primary outcome was trial enrolment among patients born in non-English speaking countries (CALD) versus English speaking countries (non-CALD). Multivariable logistic regression evaluated CALD status as a predictor of trial participation. Moderators of trial participation by the different CALD groups, namely those whose preferred language was English (CALD-PLE) or was not English (CALD-PLNE), were examined by testing interactions between CALD status and other demographic and clinical variables. Results A total of 19 453 patients were analyzed (54.9% non-CALD, 16.5% CALD-PLE, 18.5% CALD-PLNE). Overall, 7.4% of patients were enrolled in a trial. Trial participation was significantly lower in CALD patients than non-CALD patients (5.7% vs 8.4%; odds ratio [OR] = 0.80; 95% confidence interval [CI], 0.69–0.91; P = 0.001). CALD-PLNE patients were less likely to participate in trials than non-CALD (OR = 0.45; 95% CI, 0.36–0.56; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text